• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Vækstaktier.dk: SMS Completes Directed Share Issue

Scandinavian Medical Solutions

SMS today announced that the company has decided to complete a directed share issue to members of the Board of Directors and executive management.

SMS has decided to carry out a directed share issue without pre-emptive rights for the company’s existing shareholders. The subscription price for the new shares has been set at DKK 2.75 per share, corresponding to yesterday’s closing price. The share issue provides the company with net proceeds of DKK 4.8 million and underscores management’s continued confidence in the company, its strategy, and its future development through a self-financed investment in the company.

The new shares have been subscribed for by Chairman of the Board Jonas Wulff Møller and Board Member Morten Rasmussen, each of whom has subscribed for 454,545 shares. Finally, Executive Management Member Jens Krohn has subscribed for 909,090 shares. Completion of the directed share issue will result in dilution of approximately 6.14% for the company’s existing shareholders.

Contacts
Email: markus@vaekstaktier.dk
Telephone: +45 50 42 99 18

About Us
Disclaimer: Vaekstaktier has a paid IR-partnership with the company mentioned. The content is for informational purposes and is a redistribution of the company’s own communications.

Website: vaekstaktier.dk

Attachments
SMS Completes Directed Share Issue